XML 36 R24.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCKHOLDERS' DEFICIT (Tables)
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of Share-Based Payment Arrangement, Cost by Plan
The following table presents the Company's total share based compensation expense by award type for the three and six months ended June 30, 2024 and 2023:

(In thousands)Three Months Ended
June 30,		Six Months Ended
June 30,
2024202320242023
RSUs$5,085 $5,536 $10,011 $11,638 
Performance RSUs1,412 2,300 4,201 4,232 
Options723 1,376 1,488 3,494 
Total Share Based Compensation Expense(1)
$7,220 $9,212 $15,700 $19,364 
(1) Total share based compensation expense includes $0.5 million of expense from cash settled awards for the six months ended June 30, 2024. Share based compensation expense from cash settled awards was immaterial for the three months ended June 30, 2024. Total share based compensation expense includes $0.3 million of expense from cash settled awards for the three and six months ended June 30, 2023.
Schedule of Computation of Income (Loss) per Share
Computation of Loss per Share
(In thousands, except per share data)Three Months Ended
June 30,		Six Months Ended
June 30,
 2024202320242023
NUMERATOR:    
Net loss attributable to the Company – common shares$(981,658)$(884,470)$(1,000,166)$(1,106,730)
DENOMINATOR(1):
   
Weighted average common shares outstanding - basic151,137 149,179 150,466 148,774 
  Stock options and restricted stock(2):
— — — — 
Weighted average common shares outstanding - diluted151,137 149,179 150,466 148,774 
Net loss attributable to the Company per common share:   
Basic$(6.50)$(5.93)$(6.65)$(7.44)
Diluted$(6.50)$(5.93)$(6.65)$(7.44)
(1) All of the outstanding Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the three and six months ended June 30, 2024 and 2023.
(2) Outstanding equity service awards representing 15.1 million and 13.8 million shares of Class A common stock of the Company for the three months ended June 30, 2024 and 2023, respectively, and 15.5 million and 12.7 million for the six months ended June 30, 2024 and 2023, respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.